Precision medicine emerged to prominence over the last decade with a major impact on outcomes, allowing for personalized cancer treatments. The speed of scientific breakthroughs in precision medicine is leading to groundbreaking therapies. Novel Artificial Intelligence (AI) engines can potentially help to identify patterns and allow teams to uncover innovative strategies for specific cancers and individual patient populations. Today more than ever before, physician-scientists working with patients need real-time information aimed at creating an improved, value-based survivorship.
The first Miami Precision Medicine (MPM) international conference will bring together diverse experts in the field to share their knowledge and approaches in moving precision medicine towards routine practice. The course will examine the treatment landscape for various cancer types based on published and emerging data. An interdisciplinary molecular tumor board case discussion will illustrate the role of genomic alterations in selecting targeted treatments as well as present relevant precision medicine clinical trials.
Patients and advocacy groups will have an opportunity to share their insight, learn about promising clinical trials and partner with physicians to develop new strategies tailored to their specific needs.
